Arginyl-Glutamine
Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].
Product Specifications
CAS Number
[2483-17-2]
Product Name Alternative
H-Arg-Gln-OH
UNSPSC
12352209
Target
VEGFR
Type
Peptides
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/arginyl-glutamine.html
Solubility
10 mM in DMSO
Smiles
N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O
Molecular Formula
C11H22N6O4
Molecular Weight
302.33
References & Citations
[1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
042762-ML490 100 µL
TFCP2L1, CT (TFCP2L1, CRTR1, LBP9, Transcription factor CP2-like protein 1, CP2-related transcriptional repressor 1, Transcription factor LBP-9) (MaxLight 490) discontinued
Ask
View Details 
GTR15354265 1 Vial
Lentiviral human MARCHF11 sgRNA gene knockout kit - Lentiviral human MARCHF11 sgRNA gene knockout kit (plasmid)
Ask
View Details